Imaging Genetic Information - Nanotechnology for Biomedical Imaging and Diagnostics - page 384

[8] Kaur S, Venktaraman g, Jain m, Senapati S, garg PK, Batra SK. Recent trends in
antibody-based oncologic imaging. cancer Lett 2012; 315 :97-111.
[9] Soontornworajit B, Wang Y. Nucleic acid aptamers for clinical diagnosis: cell detection
and molecular imaging. Anal Bioanal chem 2011; 399 :1591-1599.
[10] Xing H, Wong NY, Xiang Y, Lu Y. DNA aptamer functionalized nanomaterials for intra-
cellular analysis, cancer cell imaging and drug delivery. curr Opin chem Biol 2012; 16 :
429-435.
[11] Dunphy mP, Lewis JS. Radiopharmaceuticals in preclinical and clinical development for
monitoring of therapy with PeT. J. Nucl. med 2009; 50 suppl 1 :106S-121S.
[12] Skotland T. molecular imaging: challenges of bringing imaging of intracellular targets
into common clinical use. contrast media mol Imaging 2012; 7 :1-6.
[13] Yang cJ, Jockusch S, Vicens m, Turro NJ, Tan W. Light-switching excimer probes for
rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A 2005;
102 :17278-17283.
[14] Shi H, He X, Wang K, Wu X, Ye X, guo Q, Tan W, Qing Z, Yang X, Zhou B. Activatable
aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane pro-
tein-triggered conformation alteration. Proc Natl Acad Sci U S A 2011; 108 :3900-3905.
[15] Lee S, Xie J, chen X. Activatable molecular probes for cancer imaging. curr Top med
chem 2010; 10 :1135-1144.
[16] ceulemans S, van der Ven K, Del-Favero J. Targeted screening and validation of copy
number variations. methods mol Biol 2012; 838 :311-328.
[17] Deshpande A, White PS. multiplexed nucleic acid-based assays for molecular diagnos-
tics of human disease. expert Rev mol Diagn 2012; 12 :645-659.
[18] gorreta F, carbone W, Barzaghi D. genomic profiling: cDNA arrays and oligoarrays.
methods mol Biol 2012; 823 :89-105.
[19] Yu Ac, Vatcher g, Yue X, Dong Y, Li mH, Tam PH, Tsang PY, Wong AK, Hui mH, Yang
B, Tang H, Lau LT. Nucleic acid-based diagnostics for infectious diseases in public
health affairs. Front med 2012; 6 :173-186.
[20] mirkin Sm. DNA structures, repeat expansions and human hereditary disorders. curr
Opin Struct Biol 2006; 16 :351-358.
[21] Knauert mP, glazer Pm. Triplex forming oligonucleotides: sequence-specific tools for
gene targeting. Hum mol genet 2001; 10 :2243-2251.
[22] Praseuth D, guieysse AL, Helene c. Triple helix formation and the antigene strategy for
sequence-specific control of gene expression. Biochim Biophys Acta 1999; 1489 :181-206.
[23] Izvolsky KI, Demidov VV, Nielsen Pe, Frank-Kamenetskii mD. Sequence-specific
protection of duplex DNA against restriction and methylation enzymes by pseudocom-
plementary PNAs. Biochemistry 2000; 39 :10908-10913.
[24] Nielsen Pe. Sequence-selective targeting of duplex DNA by peptide nucleic acids. curr
Opin mol Ther 2010; 12 :184-191.
[25] Dervan PB. molecular recognition of DNA by small molecules. Bioorg med chem
2001; 9 :2215-2235.
[26] ghosh I, Stains cI, Ooi AT, Segal DJ. Direct detection of double-stranded DNA: molecular
methods and applications for DNA diagnostics. mol Biosyst 2006; 2 :551-560.
[27] Klug A. The discovery of zinc fingers and their development for practical applications in
gene regulation and genome manipulation. Q Rev Biophys 2010; 43 :1-21.